Immunohistochemical and molecular markers in breast phyllodes tumors

Applied Immunohistochemistry and Molecular Morphology

Volumn 19, Issue 2, 2011, Pages 119-125

  Korcheva, Veselina B ^a   Levine, Judith ^b   Beadling, Carol ^b   Warrick, Andrea ^b   Countryman, Gayle ^b   Olson, Neal R ^c   Heinrich, Michael C ^b,d   Corless, Christopher L ^a,b   Troxell, Megan L ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c KAISER PERMANENTE   (United States)

^d PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Breast; cyclin D1; FBX4; KIT; MDM2; phospho H3; phyllodes; TP53

Indexed keywords

ABELSON KINASE; B RAF KINASE; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 3; FLT3 LIGAND; HISTONE H3; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; PLATELET DERIVED GROWTH FACTOR A; PROTEIN AKT3; PROTEIN KINASE B; PROTEIN KINASE B BETA; PROTEIN MDM2; PROTEIN P53; PROTEIN RET; PROTEIN TYROSINE PHOSPHATASE SHP 2; RAS PROTEIN; SCATTER FACTOR RECEPTOR; SOS PROTEIN; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR FBX4; TUMOR MARKER; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; BENIGN TUMOR; CANCER GRADING; CANCER SIZE; CLINICAL ARTICLE; CYSTOSARCOMA PHYLLOIDES; FEMALE; FIBROADENOMA; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; METASTASIS; MITOSIS; PATHOGENESIS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCREENING; STAINING; TUMOR GENE; TUMOR SUPPRESSOR GENE;

AMINO ACID SUBSTITUTION; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; HISTONES; HUMANS; IMMUNOHISTOCHEMISTRY; PHOSPHORYLATION; PHYLLODES TUMOR; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79951943797     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181f5349a     Document Type: Article

References (43)

1. Bellocq JP, Magro G. Fibroepithelial tumors. In: Tavassoli FA, Devilee P, eds. World Health Organization Classification of Tumors Pathology & Genetics: Tumours of the Breast and Female Genital Organs. Lyon, France: IARC Press; 2003:99-103.
2. Esposito NN, Mohan D, Brufsky A, et al. Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 cases. Arch Pathol Lab Med. 2006;130:1516-1521. (Pubitemid 44520719)
3. Giri D. Recurrent challenges in the evaluation of fibroepithelial lesions. Arch Pathol Lab Med. 2009;133:713-721.
4. Lee AH. Recent developments in the histological diagnosis of spindle cell carcinoma, fibromatosis and phyllodes tumour of the breast. Histopathology. 2008;52:45-57. (Pubitemid 350265183)
5. Telli ML, Horst KC, Guardino AE, et al. Phyllodes tumors of the breast: natural history, diagnosis, and treatment. J Natl Compr Canc Netw. 2007;5:324-330. (Pubitemid 46465553)
6. Kleer CG, Giordano TJ, Braun T, et al. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast. Mod Pathol. 2001;14:185-190. (Pubitemid 32246822)
7. Dunne B, Lee AH, Pinder SE, et al. An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast. Hum Pathol. 2003;34:1009-1015. (Pubitemid 37315252)
8. Tan PH, Jayabaskar T, Yip G, et al. p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study. Mod Pathol. 2005;18:1527-1534. (Pubitemid 41670650)
9. Kuijper A, de Vos RA, Lagendijk JH, et al. Progressive deregulation of the cell cycle with higher tumor grade in the stroma of breast phyllodes tumors. Am J Clin Pathol. 2005;123:690-698. (Pubitemid 40586486)
10. Kersting C, Kuijper A, Schmidt H, et al. Amplifications of the epidermal growth factor receptor gene (egfr) are common in phyllodes tumors of the breast and are associated with tumor progression. Lab Invest. 2006;86:54-61. (Pubitemid 43250968)
11. Tsai WC, Jin JS, Yu JC, et al. CD10, actin, and vimentin expression in breast phyllodes tumors correlates with tumor grades of the WHO grading system. Int J Surg Pathol. 2006;14:127-131.
12. Lu YJ, Birdsall S, Osin P, et al. Phyllodes tumors of the breast analyzed by comparative genomic hybridization and association of increased 1q copy number with stromal overgrowth and recurrence. Genes Chromosomes Cancer. 1997;20:275-281. (Pubitemid 27484103)
13. Bot FJ, Sleddens HF, Dinjens WN. Molecular assessment of clonality leads to the identification of a new germ line TP53 mutation associated with malignant cystosarcoma phyllodes and soft tissue sarcoma. Diagn Mol Pathol. 1998;7:295-301. (Pubitemid 29177571)
14. Jee KJ, Gong G, Ahn SH, et al. Gain in 1q is a common abnormality in phyllodes tumours of the breast. Anal Cell Pathol. 2003;25:89-93. (Pubitemid 36443409)
15. Tse GM, Putti TC, Kung FY, et al. Increased p53 protein expression in malignant mammary phyllodes tumors. Mod Pathol. 2002; 15:734-740. (Pubitemid 34787309)
16. Wang ZC, Buraimoh A, Iglehart JD, et al. Genome-wide analysis for loss of heterozygosity in primary and recurrent phyllodes tumor and fibroadenoma of breast using single nucleotide polymorphism arrays. Breast Cancer Res Treat. 2006;97:301-309. (Pubitemid 43945760)
17. Jones AM, Mitter R, Springall R, et al. A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence. J Pathol. 2008;214:533-544. (Pubitemid 351482269)
18. Jones AM, Mitter R, Poulsom R, et al. mRNA expression profiling of phyllodes tumours of the breast: identification of genes important in the development of borderline and malignant phyllodes tumours. J Pathol. 2008;216:408-417.
19. Lv S, Niu Y, Wei L, et al. Chromosomal aberrations and genetic relations in benign, borderline and malignant phyllodes tumors of the breast: a comparative genomic hybridization study. Breast Cancer Res Treat. 2008;112:411-418.
20. Kuijper A, Snijders AM, Berns EM, et al. Genomic profiling by array comparative genomic hybridization reveals novel DNA copy number changes in breast phyllodes tumours. Cell Oncol. 2009;31:31-39.
21. Lae M, Vincent-Salomon A, Savignoni A, et al. Phyllodes tumors of the breast segregate in two groups according to genetic criteria. Mod Pathol. 2007;20:435-444. (Pubitemid 46482367)
22. Pratilas CA, Hanrahan AJ, Halilovic E, et al. Genetic predictors of MEK dependence in non-small cell lung cancer. Cancer Res. 2008;68:9375-9383.
23. Troxell ML, Levine J, Beadling C, et al. High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast. Mod Pathol. 2010;23:27-37.
24. Tyner JW, Fletcher L, Wang E, et al. Hepatocyte Growth Factor Receptor (MET) sequence variants R970C and T992I do not exhibit transforming capacity. Cancer Res. 2010;70:6233-6237.
25. Winston JT, Koepp DM, Zhu C, et al. A family of mammalian F-box proteins. Curr Biol. 1999;9:1180-1182. (Pubitemid 29527104)
26. Cenciarelli C, Chiaur DS, Guardavaccaro D, et al. Identification of a family of human F-box proteins. Curr Biol. 1999;9: 1177-1179. (Pubitemid 29527103)
27. Barbash O, Zamfirova P, Lin DI, et al. Mutations in Fbx4 inhibit dimerization of the SCF(Fbx4) ligase and contribute to cyclin D1 overexpression in human cancer. Cancer Cell. 2008;14: 68-78. (Pubitemid 351885497)
28. Jacklin RK, Ridgway PF, Ziprin P, et al. Optimising preoperative diagnosis in phyllodes tumour of the breast. J Clin Pathol. 2006;59: 454-459.
29. Feakins RM, Mulcahy HE, Nickols CD, et al. p53 expression in phyllodes tumours is associated with histological features of malignancy but does not predict outcome. Histopathology. 1999;35: 162-169. (Pubitemid 29378517)
30. Millar EK, Beretov J, Marr P, et al. Malignant phyllodes tumours of the breast display increased stromal p53 protein expression. Histopathology. 1999;34:491-496. (Pubitemid 29284622)
31. Kuenen-Boumeester V, Henzen-Logmans SC, Timmermans MM, et al. Altered expression of p53 and its regulated proteins in phyllodes tumours of the breast. J Pathol. 1999;189:169-175. (Pubitemid 29448908)
32. Shpitz B, Bomstein Y, Sternberg A, et al. Immunoreactivity of p53, Ki-67, and c-erbB-2 in phyllodes tumors of the breast in correlation with clinical and morphologic features. J Surg Oncol. 2002;79:86-92. (Pubitemid 34111933)
33. Gatalica Z, Finkelstein S, Lucio E, et al. p53 protein expression and gene mutation in phyllodes tumors of the breast. Pathol Res Pract. 2001;197:183-187. (Pubitemid 32273376)
34. Mazoyer S, Lalle P, Moyret-Lalle C, et al. Two germ-line mutations affecting the same nucleotide at codon 257 of p53 gene, a rare site for mutations. Oncogene. 1994;9:1237-1239. (Pubitemid 24095034)
35. Woolley PV, Gollin SM, Riskalla W, et al. Cytogenetics, immunostaining for fibroblast growth factors, p53 sequencing, and clinical features of two cases of cystosarcoma phyllodes. Mol Diagn. 2000;5: 179-190.
36. Naski N, Gajjar M, Bourougaa K, et al. The p53 mRNA-Mdm2 interaction. Cell Cycle. 2009;8:31-34.
37. Gibson PC, Cooper K. CD117 (KIT): a diverse protein with selective applications in surgical pathology. Adv Anat Pathol. 2002;9: 65-69.
38. Miettinen M, Lasota J. KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol. 2005; 13:205-220. (Pubitemid 41209013)
39. Djordjevic B, Hanna WM. Expression of c-kit in fibroepithelial lesions of the breast is a mast cell phenomenon. Mod Pathol. 2008;21:1238-1245.
40. Carvalho S, e Silva AO, Milanezi F, et al. c-KIT and PDGFRA in breast phyllodes tumours: overexpression without mutations? J Clin Pathol. 2004;57:1075-1079. (Pubitemid 39331359)
41. Chen CM, Chen CJ, Chang CL, et al. CD34, CD117, and actin expression in phyllodes tumor of the breast. J Surg Res. 2000; 94:84-91.
42. Sawyer EJ, Poulsom R, Hunt FT, et al. Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit. J Pathol. 2003;200:59-64. (Pubitemid 36592637)
43. Sawyer EJ, Hanby AM, Rowan AJ, et al. The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours. J Pathol. 2002;196:437-444. (Pubitemid 34262856)